Annual Net Income
-$20.25 M
-$436.00 K-2.20%
31 December 2023
Summary:
Vaccinex annual net profit is currently -$20.25 million, with the most recent change of -$436.00 thousand (-2.20%) on 31 December 2023. During the last 3 years, it has risen by +$2.13 million (+9.51%). VCNX annual net income is now -45.24% below its all-time high of -$13.94 million, reached on 31 December 2016.VCNX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$5.73 M
-$101.00 K-1.79%
30 September 2024
Summary:
Vaccinex quarterly net profit is currently -$5.73 million, with the most recent change of -$101.00 thousand (-1.79%) on 30 September 2024. Over the past year, it has dropped by -$2.42 million (-72.81%). VCNX quarterly net income is now -121.31% below its all-time high of -$2.59 million, reached on 31 December 2017.VCNX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$18.58 M
-$820.00 K-4.62%
30 September 2024
Summary:
Vaccinex TTM net profit is currently -$18.58 million, with the most recent change of -$820.00 thousand (-4.62%) on 30 September 2024. Over the past year, it has increased by +$1.67 million (+8.27%). VCNX TTM net income is now -224.94% below its all-time high of -$5.72 million, reached on 31 March 2017.VCNX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VCNX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -72.8% | +8.3% |
| 3 y3 years | +9.5% | -23.8% | +17.0% |
| 5 y5 years | +36.4% | +9.4% | +41.7% |
VCNX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2.2% | +9.5% | -72.8% | +18.8% | -4.6% | +17.0% |
| 5 y | 5 years | -2.2% | +36.4% | -72.8% | +34.5% | -4.6% | +41.7% |
| alltime | all time | -45.2% | +36.4% | -121.3% | +36.8% | -224.9% | +45.3% |
Vaccinex Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$5.73 M(+1.8%) | -$18.58 M(+4.6%) |
| June 2024 | - | -$5.63 M(+44.5%) | -$17.76 M(-7.4%) |
| Mar 2024 | - | -$3.90 M(+17.5%) | -$19.19 M(-5.3%) |
| Dec 2023 | -$20.25 M(+2.2%) | -$3.32 M(-32.5%) | -$20.25 M(-8.0%) |
| Sept 2023 | - | -$4.91 M(-30.4%) | -$22.01 M(+0.7%) |
| June 2023 | - | -$7.06 M(+42.3%) | -$21.86 M(+8.3%) |
| Mar 2023 | - | -$4.96 M(-2.3%) | -$20.18 M(+1.9%) |
| Dec 2022 | -$19.82 M(-11.5%) | -$5.08 M(+6.7%) | -$19.82 M(+2.3%) |
| Sept 2022 | - | -$4.76 M(-11.6%) | -$19.37 M(-2.3%) |
| June 2022 | - | -$5.38 M(+17.1%) | -$19.82 M(-2.9%) |
| Mar 2022 | - | -$4.59 M(-0.8%) | -$20.40 M(-8.8%) |
| Dec 2021 | -$22.38 M(-22.4%) | -$4.63 M(-11.0%) | -$22.38 M(-7.5%) |
| Sept 2021 | - | -$5.21 M(-12.8%) | -$24.19 M(-12.8%) |
| June 2021 | - | -$5.97 M(-9.2%) | -$27.74 M(-1.9%) |
| Mar 2021 | - | -$6.57 M(+2.0%) | -$28.27 M(-2.0%) |
| Dec 2020 | -$28.85 M | -$6.45 M(-26.4%) | -$28.85 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$8.75 M(+34.7%) | -$28.73 M(+4.0%) |
| June 2020 | - | -$6.50 M(-9.1%) | -$27.62 M(-7.8%) |
| Mar 2020 | - | -$7.15 M(+13.0%) | -$29.95 M(-6.0%) |
| Dec 2019 | -$31.86 M(+7.9%) | -$6.33 M(-17.2%) | -$31.86 M(-6.2%) |
| Sept 2019 | - | -$7.64 M(-13.4%) | -$33.99 M(+3.2%) |
| June 2019 | - | -$8.83 M(-2.6%) | -$32.94 M(+7.2%) |
| Mar 2019 | - | -$9.07 M(+7.3%) | -$30.72 M(+4.1%) |
| Dec 2018 | -$29.52 M(+57.7%) | -$8.45 M(+28.0%) | -$29.52 M(+24.8%) |
| Sept 2018 | - | -$6.60 M(-0.1%) | -$23.66 M(+4.7%) |
| June 2018 | - | -$6.61 M(-16.0%) | -$22.60 M(+8.3%) |
| Mar 2018 | - | -$7.86 M(+203.6%) | -$20.87 M(+11.5%) |
| Dec 2017 | -$18.72 M(+34.3%) | -$2.59 M(-53.2%) | -$18.72 M(+16.1%) |
| Sept 2017 | - | -$5.54 M(+13.5%) | -$16.13 M(+52.2%) |
| June 2017 | - | -$4.88 M(-14.7%) | -$10.60 M(+85.3%) |
| Mar 2017 | - | -$5.72 M | -$5.72 M |
| Dec 2016 | -$13.94 M | - | - |
FAQ
- What is Vaccinex annual net profit?
- What is the all time high annual net income for Vaccinex?
- What is Vaccinex quarterly net profit?
- What is the all time high quarterly net income for Vaccinex?
- What is Vaccinex quarterly net income year-on-year change?
- What is Vaccinex TTM net profit?
- What is the all time high TTM net income for Vaccinex?
- What is Vaccinex TTM net income year-on-year change?
What is Vaccinex annual net profit?
The current annual net income of VCNX is -$20.25 M
What is the all time high annual net income for Vaccinex?
Vaccinex all-time high annual net profit is -$13.94 M
What is Vaccinex quarterly net profit?
The current quarterly net income of VCNX is -$5.73 M
What is the all time high quarterly net income for Vaccinex?
Vaccinex all-time high quarterly net profit is -$2.59 M
What is Vaccinex quarterly net income year-on-year change?
Over the past year, VCNX quarterly net profit has changed by -$2.42 M (-72.81%)
What is Vaccinex TTM net profit?
The current TTM net income of VCNX is -$18.58 M
What is the all time high TTM net income for Vaccinex?
Vaccinex all-time high TTM net profit is -$5.72 M
What is Vaccinex TTM net income year-on-year change?
Over the past year, VCNX TTM net profit has changed by +$1.67 M (+8.27%)